{"protocolSection":{"identificationModule":{"nctId":"NCT05885022","orgStudyIdInfo":{"id":"CFP-101, CFP-103"},"organization":{"fullName":"Myra Vision Inc.","class":"INDUSTRY"},"briefTitle":"Feasibility Clinical Evaluation of the Calibreye System","officialTitle":"Feasibility Clinical Evaluation of the Calibreye System"},"statusModule":{"statusVerifiedDate":"2025-05","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-05-31","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2027-12","type":"ESTIMATED"},"completionDateStruct":{"date":"2028-12","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-05-22","studyFirstSubmitQcDate":"2023-05-22","studyFirstPostDateStruct":{"date":"2023-06-01","type":"ACTUAL"},"lastUpdateSubmitDate":"2025-05-13","lastUpdatePostDateStruct":{"date":"2025-05-15","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Myra Vision Inc.","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":true,"isUnapprovedDevice":true,"isUsExport":true},"descriptionModule":{"briefSummary":"To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.","detailedDescription":"This is a prospective, nonrandomized, open-label feasibility clinical trial, to evaluate the surgical procedure, safety and effectiveness of the Calibreye System in reducing intraocular pressure in subjects with open angle glaucoma."},"conditionsModule":{"conditions":["Glaucoma, Open-Angle"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":60,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Investigational Device Arm","type":"EXPERIMENTAL","description":"Subjects will receive a Calibreye glaucoma device (permanent implant)","interventionNames":["Device: Calibreye System"]}],"interventions":[{"type":"DEVICE","name":"Calibreye System","description":"Implantation of a glaucoma device to reduce intraocular pressure","armGroupLabels":["Investigational Device Arm"],"otherNames":["Glaucoma device, Glaucoma implant, Aqueous Shunt"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Intraocular Pressure","description":"Percent change in IOP from baseline to the 12-month visit","timeFrame":"12 Months"},{"measure":"Adverse Events","description":"Number and percentage of subjects having any adverse event","timeFrame":"12 Months"}],"secondaryOutcomes":[{"measure":"Glaucoma Medication Usage","description":"Change in number of medications used compared to baseline","timeFrame":"12 Months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Open angle, pseudoexfoliative or pigmentary glaucoma\n* IOP at preoperative visit of ≥ 18mmHg and ≤ 45mmHg\n* Visual field mean deviation score of -3dB or worse\n* Area of healthy, free and mobile conjunctiva in the target quadrant\n* Shaffer angle grade ≥ 3 in the target quadrant\n\nExclusion Criteria:\n\n* Angle closure glaucoma\n* Congenital, neovascular or other secondary glaucomas\n* Previous intraocular surgery (with the exception of laser trabeculoplasty or uncomplicated phacoemulsification with IOL occurring \\> 3 months prior to the preoperative visit)\n* Previous glaucoma shunt/valve in the target quadrant\n* Clinically significant inflammation or infection in the study eye within 30 days prior to the preoperative visit\n* History of corneal surgery, corneal opacities or corneal disease\n* Active diabetic retinopathy","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Shienal Patel","role":"CONTACT","phone":"14085602500","email":"info@myravision.com"},{"name":"Michelle Tran","role":"CONTACT","phone":"14085602500","email":"info@myravision.com"}],"overallOfficials":[{"name":"Keith Barton, MD","affiliation":"Moorfields Eye Hospital NHS Foundation Trust","role":"STUDY_CHAIR"}],"locations":[{"facility":"Dr. Agarwal's Eye Hospital Ltd.","status":"ACTIVE_NOT_RECRUITING","city":"Chennai","zip":"600018","country":"India","geoPoint":{"lat":13.08784,"lon":80.27847}},{"facility":"Centro Oftalmologico de Chihuahua","status":"RECRUITING","city":"Chihuahua","country":"Mexico","contacts":[{"name":"Mayra Salinas","role":"CONTACT","phone":"52 61 4364 7898","email":"mayra_dj@hotmail.com"},{"name":"Ana Cristina Luna, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":28.63528,"lon":-106.08889}},{"facility":"Oftalmología Láser de Puebla S.C.","status":"RECRUITING","city":"Puebla","zip":"72540","country":"Mexico","contacts":[{"name":"Aimee Hernandez","role":"CONTACT","phone":"(22) 2257-0970","email":"aimeehdz20@gmail.com"},{"name":"Gabriel Salomón Lazcano Gómez, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":19.03793,"lon":-98.20346}},{"facility":"Panama Eye Center","status":"RECRUITING","city":"Panama City","country":"Panama","contacts":[{"name":"Idabel Orillac","role":"CONTACT","phone":"+507 269 7475","email":"idabelo28@gmail.com"},{"name":"Ernesto Calvo, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":8.9936,"lon":-79.51973}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2025-07-07","removedCountries":["Georgia"]},"conditionBrowseModule":{"meshes":[{"id":"D005902","term":"Glaucoma, Open-Angle"}],"ancestors":[{"id":"D005901","term":"Glaucoma"},{"id":"D009798","term":"Ocular Hypertension"},{"id":"D005128","term":"Eye Diseases"}],"browseLeaves":[{"id":"M9013","name":"Glaucoma","relevance":"LOW"},{"id":"M9014","name":"Glaucoma, Open-Angle","asFound":"Glaucoma, Open-Angle","relevance":"HIGH"},{"id":"M10024","name":"Hypertension","relevance":"LOW"},{"id":"M12731","name":"Ocular Hypertension","relevance":"LOW"},{"id":"M8271","name":"Eye Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC11","name":"Eye Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC14","name":"Heart and Blood Diseases"}]}},"hasResults":false}